This Article Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Feldman, R. D. Articles by Christianson, J. B. Search for Related Content PubMed PubMed Citation Articles by Feldman, R. D. Articles by Christianson, J. B. Related Collections Managed Care State/Local Issues

Health Affairs, Vol 18, Issue 4, 96-104
Copyright © 1999 by Project HOPE

Health Tracking

HMO consolidations: how national mergers affect local markets

The health maintenance organization (HMO) industry has undergone a wave of national consolidations in recent years. The most notable among these were between United HealthCare and MetraHealth (1995), PacifiCare Health Systems and FHP International (1996), Aetna Life and Casualty and U.S. Healthcare (1996), and Aetna and Prudential's health care unit (1999). This paper examines HMO consolidation from 1994 to 1997, looking first at concentration at the national level and then at the consequences of national consolidations for local markets. Whereas earlier mergers may have caused only a small increase in the type of local market concentration that may increase prices, later and currently proposed mergers may be motivated by considerations of increasing local market concentration. However, the concentration-increasing effect of national mergers was offset by the concentration-decreasing effect of HMO entry and growth. The analyses suggest that antitrust policy still has a role to play in ensuring that HMO markets remain open to new entry and in evaluating the effect of national mergers on local market concentration.

                      What's this?

This article has been cited by other articles:

				M. E. Matheny, L. Ohno-Machado, and F. S. Resnic Monitoring Device Safety in Interventional Cardiology J. Am. Med. Inform. Assoc., March 1, 2006; 13(2): 180 - 187. [Abstract] [Full Text] [PDF]

				J. M. Grossman and P. B. Ginsburg As The Health Insurance Underwriting Cycle Turns: What Next? Health Aff., November 1, 2004; 23(6): 91 - 102. [Abstract] [Full Text] [PDF]

				R. A. Deyo Gaps, Tensions, and Conflicts in the FDA Approval Process: Implications for Clinical Practice J Am Board Fam Med, March 1, 2004; 17(2): 142 - 149. [Abstract] [Full Text] [PDF]